Monogenic diabetes mellitus due to defects in insulin secretion

Area of Science:

• Endocrinology
• Genetics
• Metabolic Disorders

Background:

• Monogenic diabetes mellitus results from single gene mutations affecting pancreatic beta cell insulin secretion.
• These forms represent up to 5% of all diabetes mellitus cases and are frequently misdiagnosed as type 1 or type 2 diabetes.
• Accurate diagnosis holds significant implications for patient treatment, prognosis, and genetic counseling for families.

Purpose of the Study:

• To highlight the importance of recognizing and accurately diagnosing monogenic forms of diabetes.
• To emphasize the diagnostic criteria and implications for patient management and family risk assessment.

Main Methods:

• Clinical feature analysis including mode of inheritance, age at diagnosis, and assessment of insulin secretion.
• Genetic testing for confirmation of specific monogenic diabetes subtypes.

Main Results:

• Monogenic diabetes is characterized by impaired insulin secretion due to specific gene mutations.
• Diagnostic tools include evaluation of clinical presentation and genetic testing.
• Accurate diagnosis differentiates from type 1 and type 2 diabetes, guiding treatment and prognosis.

Conclusions:

• Accurate diagnosis of monogenic diabetes is essential due to its distinct treatment, prognosis, and familial implications.
• Clinical features and genetic testing are key to establishing diagnoses such as MODY, mitochondrial diabetes, and neonatal diabetes.